Stock comparison
Apellis Pharmaceuticals
APLS$5.25BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$73.59BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
APLS 16 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
APLS1wins
6winsJSLL.BO
54D
B84
75B
A87
67C
A92
77B
C66
59D
B75
63C
A91
61C
A95
Side-by-side metrics
| Metric | APLS | JSLL.BO |
|---|---|---|
| Market cap | $5.25B | $73.59B Winner |
| P/E (TTM) | 38.8x | 33.2x Winner |
| EV/EBIT | 96.0x | 24.1x Winner |
| ROIC (TTM) | 18.11% | 39.15% Winner |
| Gross margin | Winner: 90.12% | 88.58% |
| Net margin | 12.06% | 27.68% Winner |
| Revenue CAGR 5y | Winner: 97.06% | 57.81% |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | 1.1x | 0.3x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
APLS leads on
- Revenue CAGR 5y97.06%vs 57.81%+40%
JSLL.BO leads on
- Market cap$73.59Bvs $5.25B+93%
- Debt / Equity0.3xvs 1.1x+76%
- EV/EBIT24.1xvs 96.0x+75%
- Net margin27.68%vs 12.06%+56%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.